CardiffLex's profile picture. Cardiff Lexington is a public holding company (OTCQB: CDIX) that acquires and opertes small-to-mid size healthcare companies.

Cardiff Lexington Corporation

@CardiffLex

Cardiff Lexington is a public holding company (OTCQB: CDIX) that acquires and opertes small-to-mid size healthcare companies.

Cardiff Lexington (OTCQB: CDIX) announces the planned retirement of Chairman Daniel Thompson after 25 years of service. Alex Cunningham, President & CEO, will assume the role of Chairman. Link to PR: investor.cardifflexington.com/news/news-deta… #InvestorRelations #Leadership #Healthcare


Cardiff Lexington (OTCQB: CDIX) subsidiary Nova Ortho & Spine has completed its first procedures at Doctor’s Memorial Hospital in Perry, FL. Full press release: investor.cardifflexington.com/news/news-deta… $CDIX#InvestorRelations #Healthcare


📣 Cardiff Lexington has entered an advisory agreement with Greentree Financial Group to support our uplisting strategy. Read more: investor.cardifflexington.com/news/news-deta… $CDIX #CardiffLexington


Cardiff Lexington has announced Q3 2025 results. Join our earnings call at today 9 AM ET today to learn more. 🔗Press Release: investor.cardifflexington.com/news/news-deta… $CDIX #Earnings #IR #FinancialResults


Cardiff Lexington will release Q3 2025 earnings results and host its earnings call on Nov 14 at 9 AM ET. 🔗 Press release: investor.cardifflexington.com/news/news-deta… #Earnings #IR #CardiffLexington #Orthopedic #Healthcare $CDIX


ICYMI: Cardiff Lexington (OTCQB: CDIX) announced its second quarter 2025 financial results. 📊 Listen to a replay of the earnings call and read the full press release at this link: investor.cardifflexington.com/news/news-deta… $CDIX #Earnings #InvestorRelations #FinancialResults


Cardiff Lexington (OTCQB: CDIX) announced Q2 2025 financial results and will host an earnings call today at 9:00 AM ET. 🔗 View our full press release and access the call at this link: investor.cardifflexington.com/news/news-deta… $CDIX #Earnings #IR #FinancialResults


📢 Cardiff Lexington (OTCQB: CDIX) reports Q2 2025 results on Tuesday, August 26. 🎙️ Investor call & webcast @ 9:00 AM ET. For call details and to view the full press release, please visit this link: investor.cardifflexington.com/news/news-deta… $CDIX #Earnings #InvestorCall


Cardiff Lexington will host its second quarter 2025 earnings call on Tuesday, August 12 at 5 pm ET. Please click the link below to access dial in and webcasting information. investor.cardifflexington.com/news/news-deta… $CDIX #CardiffLexington #2Q25Earnings #Orthopedic #Healthcare


📈 Exciting news! Cardiff Lexington Corporation ($CDIX) has successfully uplisted to the OTCQB Venture Market, effective May 15, 2025, enhancing visibility and the Company’s commitment to long-term growth. Read more: investor.cardifflexington.com/news/news-deta…


🚀 Cardiff Lexington (OTC: $CDIX) reports strong Q1 2025: 📈 Revenue up 26% YoY to $2.9M 💼 Operating income up 148% 📊 Gross margins of 63% 🔗 View the full press release at this link: investor.cardifflexington.com/news/news-deta… #CDIX #Earnings #Healthcare #Orthopedics


We have announced our financial results for the second quarter of 2024. Read our full press release at this link: investor.cardifflexington.com/news/news-deta… #CardiffLexington #Earnings #NovaOrthoandSpine #Orthopedics #Growth


We’re pleased to announce that we’ve opened a new Nova Ortho and Spine location in Orlando. This is our 12th total location and 11th in the state of Florida. Read the full press release at this link: investor.cardifflexington.com/news/news-deta…


Our team at Nova Ortho and Spine is capable of addressing a broad spectrum of orthopedic injuries by delivering innovative and cutting-edge treatment options for a variety of conditions and ailments $CDIX #CardiffLexington #NovaOrthoandSpine #Orthopedics

CardiffLex's tweet image. Our team at Nova Ortho and Spine is capable of addressing a broad spectrum of orthopedic injuries by delivering innovative and cutting-edge treatment options for a variety of conditions and ailments $CDIX #CardiffLexington #NovaOrthoandSpine #Orthopedics

Today we announced the elimination of a significant amount of convertible debt from our balance sheet, simplifying and strengthening our capital structure. Read our full press release at this link: investor.cardifflexington.com/news/news-deta… $CDIX #CardiffLexington #NovaOrthoandSpine #Orthopedics


Today we announced the addition of a new controller and staff accountant as we enhance our finance team to support our anticipated growth. Read our full press release at this link: investor.cardifflexington.com/news/news-deta… $CDIX #CardiffLexington #NovaOrthoandSpine #Orthopedics


At Cardiff Lexington, we fill a crucial hole in the current healthcare market by enabling access to high-quality care for a severely underserved patient population #CardiffLexington #Healthcare #Orthopedics

CardiffLex's tweet image. At Cardiff Lexington, we fill a crucial hole in the current healthcare market by enabling access to high-quality care for a severely underserved patient population #CardiffLexington #Healthcare #Orthopedics

Cardiff Lexington has announced its first quarter 2024 earnings results highlighted by sequential revenue growth and strong gross margin performance. Click the link below to read our full press release: investor.cardifflexington.com/news/news-deta… #CardiffLexington #Earnings #NovaOrthoandSpine

CardiffLex's tweet image. Cardiff Lexington has announced its first quarter 2024 earnings results highlighted by sequential revenue growth and strong gross margin performance. Click the link below to read our full press release: investor.cardifflexington.com/news/news-deta… #CardiffLexington #Earnings #NovaOrthoandSpine

Cardiff Lexington has a proven track record of consistent revenue growth and improving operational results highlighted by five consecutive years of revenue growth and a 156% increase in full year earnings in 2023 #CardiffLexington #Earnings #Growth

CardiffLex's tweet image. Cardiff Lexington has a proven track record of consistent revenue growth and improving operational results highlighted by five consecutive years of revenue growth and a 156% increase in full year earnings in 2023 #CardiffLexington #Earnings #Growth

Through our subsidiary Nova Ortho and Spine, we are building a profitable, cash generating business that leverages one of the fastest growing segments in U.S. healthcare and a niche model to generate superior returns. Learn more at our website: investor.cardifflexington.com/overview/defau…

CardiffLex's tweet image. Through our subsidiary Nova Ortho and Spine, we are building a profitable, cash generating business that leverages one of the fastest growing segments in U.S. healthcare and a niche model to generate superior returns. Learn more at our website: investor.cardifflexington.com/overview/defau…

Loading...

Something went wrong.


Something went wrong.